February 25, 2021
Open Meeting Announcement – Oral Appliances for Obstructive Sleep Apnea, Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea, and Respiratory Assist Devices Proposed Local Coverage Determinations (LCDs)
On Tuesday, March 30, 2021 at 10 am ET, the DME MACs will host a virtual public meeting to solicit stakeholder comments for the following proposed LCDs:
This meeting is for the oral presentation of comments and for stakeholders interested in listening to the comments. In order for any oral comments to be considered, they must be submitted in writing through the formal comment process. Information related to the written comment process is available at Proposed Local Coverage Determinations (LCDs) Released for Comment – Enteral Nutrition, Oral Appliances for Obstructive Sleep Apnea, Parenteral Nutrition, Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea, and Respiratory Assist Devices.
Stakeholders interested in attending the meeting and commenting must register by Friday, March 12, 2021 at 5 pm ET. Registration is available online at https://cvent.me/mA7yNB.
By registering, you consent to your comments being recorded at the meeting. Please do not include any protected health information (PHI) or personally identifiable information (PII) in your comments.
We request that you confine your public comments at the open meeting to the proposed changes. The medical directors appreciate that you may have comments about other criteria in the proposed LCDs, and you are welcome to submit those in your written comments; however, the open meeting is to solicit public feedback on the proposed LCD changes. We ask that comments from the same organization/manufacturer be consolidated and presented by a single representative/spokesperson. If a stakeholder wishes to present an oral comment that applies to more than one of the proposed LCDs, the stakeholder should only present the comment once during the open meeting.
Any material (e.g., handouts, slides) that a registrant will present during the open meeting must be sent to DMEOpenMeeting@noridian.com by Tuesday, March 23, 2021 at 5 pm ET. In the body of the email, please include the name of the presenter and the represented organization if applicable.
Advance registration is not required for stakeholders who only wish to listen to the open meeting.
To access the meeting via teleconference, use the following information:
Conference dial-in number:
US Toll free: 1-877-309-2074
Access Code: 946-092-559
*Note: A telephone audio PIN will be provided to participants who wish to make oral comments after joining the webinar.
The amount of time allotted for oral commenters’ presentations will be determined by the number of commenters registered. Speaking time and order of commenters will be provided prior to the virtual meeting.
*IMPORTANT REMINDER: Suppliers and clinicians are cautioned not to make any changes based upon the information contained in the proposed LCDs. Proposed LCDs may be revised based upon the comments received. When all comments have been reviewed, revisions will be considered. A “Response to Comments” document will be published with the final LCDs. The final LCDs will be published in the CMS Medicare Coverage Database and accessible on individual DME MAC websites, allowing for a 45-day notice period before the final LCDs are effective.
Refer to each DME MAC web site for additional information, including access to the proposed LCDs.
Thank you for your participation in our policy development process.
Smitha M. Ballyamanda, MD, CAQSM |
Stacey V. Brennan, MD, FAAFP |
Robert D. Hoover, Jr., MD, MPH, FACP |
Peter J. Gurk, MD, CPE, CHCQM |